Advertisement
Screener

Monopar Therapeutics Inc. (MNPR) Material Contracts

Monopar Therapeutics Inc. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2026-08-12: Form 10-Q; Exhibit 10.3; Description Form of Restricted Stock Unit Grant Notice under Monopar Therapeutics Inc. 2026 Stock Incentive Plan.
  • 2026-08-12: Form 10-Q; Exhibit 10.2; Description Form of Non-qualified Stock Option Agreement under Monopar Therapeutics Inc. 2026 Stock Incentive Plan.
  • 2026-08-12: Form 10-Q; Exhibit 10.1; Description Form of Incentive Stock Option Agreement under Monopar Therapeutics Inc. 2026 Stock Incentive Plan.
  • 2026-03-27: Form 10-K; Exhibit 10.16; Description Employment Agreement with Susan Rodriguez – effective March 2, 2026.
FiledFormExhibitDescription
2026-08-1210-Q10.3Form of Restricted Stock Unit Grant Notice under Monopar Therapeutics Inc. 2026 Stock Incentive Plan
2026-08-1210-Q10.2Form of Non-qualified Stock Option Agreement under Monopar Therapeutics Inc. 2026 Stock Incentive Plan
2026-08-1210-Q10.1Form of Incentive Stock Option Agreement under Monopar Therapeutics Inc. 2026 Stock Incentive Plan
2026-03-2710-K10.16Employment Agreement with Susan Rodriguez – effective March 2, 2026
2026-03-2710-K10.6Consulting Agreement of pRx Consulting (Patrice Rioux) – effective January 1, 2026
2025-09-248-K10.1Share Purchase Agreement, dated September 24, 2025, by and between Monopar Therapeutics Inc. and Tactic Pharma, LLC.
2025-05-1310-Q10.1Consulting Agreement of pRx Consulting (Patrice Rioux) - effective January 1, 2025
2025-03-3110-K10.182016 Stock Incentive Plan, as amended
2025-03-3110-K10.17Employment Agreement of Quan Vu – effective March 3, 2025
2025-03-3110-K10.7Consulting Agreement of pRx Consulting (Patrice Rioux) – effective January 1, 2024
2024-12-238-K10.2FORM OF REGISTRATION RIGHTS AGREEMENT BY AND AMONG MONOPAR THERAPEUTICS INC. AND THE PURCHASER
2024-12-238-K10.1SECURITIES PURCHASE AGREEMENT, DATED DECEMBER 20, 2024, BY AND AMONG MONOPAR THERAPEUTICS INC. AND THE PURCHASER
2024-10-308-K10.2PLACEMENT AGENT AGREEMENT, DATED OCTOBER 28, 2024, BY AND BETWEEN MONOPAR THERAPEUTICS INC. AND RODMAN & RENSHAW LLC.
2024-10-308-K10.1FORM OF SECURITIES PURCHASE AGREEMENT, DATED OCTOBER 28, 2024, BY AND BETWEEN MONOPAR THERAPEUTICS INC. AND THE PURCHASERS PARTY THERETO.
2024-10-248-K10.2COMMON STOCK INVESTMENT AGREEMENT BETWEEN ALEXION AND MONOPAR DATED AS OF OCTOBER XX, 2024
2024-10-248-K10.1LICENSE AGREEMENT BETWEEN ALEXION AND MONOPAR DATED AS OF OCTOBER XX, 2024
2024-08-0910-Q10.1Employment Agreement of Karthik Radhakrishnan - effective July 1, 2024
2024-03-2810-K10.1License Agreement with XOMA Ltd.
2023-05-1110-Q10.1CONSULTING AGREEMENT OF PRX CONSULTING
2023-03-2310-K10.1LICENSE AGREEMENT
2022-03-2410-K10.8CONSULTING AGREEMENT
2022-03-2410-K10.7CONSULTING AGREEMENT
2022-03-2410-K10.6CONSULTING AGREEMENT
2022-03-2410-K10.5CONSULTING AGREEMENT
2022-03-2410-K10.4RESTRICTED STOCK UNIT
2022-03-2410-K10.3NONQUALIFIED STOCK
2022-03-2410-K10.2INCENTIVE STOCK OPTION
2022-03-2410-K10.1STOCK INCENTIVE PLAN
2021-08-1210-Q10EMPLOYMENT AGREEMENT OF ANDREW CITTADINE - EFFECTIVE JUNE 1, 2021
2021-08-1210-Q10EMPLOYMENT AGREEMENT OF ANDREW CITTADINE - EFFECTIVE JUNE 1, 2021
2021-03-2510-K10Consulting Agreement of pRx Consulting (Patrice Rioux) – effective January 1, 2020
2020-11-1210-Q10.1Form of Indemnification Agreement
2020-03-2710-K10Form of Non-Qualified Stock Option Agreement
2020-03-2710-K10Form of Incentive Stock Option Agreement
2020-03-2710-K10Consulting Agreement of pRx Consulting (Patrice Rioux) – effective January 1, 2019
2018-03-2610-K10.16CANCER RESEARCH UK LETTER DATED MARCH 21, 2018
2018-03-2610-K10.15TSUCHIMOTO EMPLOYMENT AGREEMENT AMENDMENT ONE
2018-03-2610-K10.14PRX CONSULTING AGREEMENT 2018
2018-03-2610-K10.13ANDERSON EMPLOYMENT AGREEMENT
2018-03-2610-K10.12PRX CONSULTING AGREEMENT 2017
2018-03-2610-K10.11MAZAR EMPLOYMENT AGREEMENT
2018-03-2610-K10.10MAZAR CONSULTING AGREEMENT
2018-03-2610-K10.9TSUCHIMOTO EMPLOYMENT AGREEMENT
2018-03-2610-K10.8TSUCHIMOTO CONSULTING AGREEMENT
2018-03-2610-K10.7ROBINSON EMPLOYMENT AGREEMENT AMENDED AND RESTATED
2018-03-2610-K10.6ROBINSON EMPLOYMENT AGREEMENT
2018-03-2610-K10.5MONOPAR THERAPEUTICS INC. 2016 STOCK INCENTIVE PLAN
2018-03-2610-K10.4TACTICGEM CONTRIBUTION AGREEMENT
2018-03-2610-K10.3ONXEO OPTION AND LICENSE AGREEMENT
2018-03-2610-K10.2XOMA LICENSE AGREEMENT
2018-03-2610-K10.1CANCER RESEARCH UK CTOA

Similar stocks

Stock NameCountryMarket CapPE Ratio
CytomX Therapeutics, Inc. (CTMX)United States$0.598B-10.25
Altimmune, Inc. (ALT)United States$0.593B-6.43
CorMedix Inc. (CRMD)United States$0.605B3.25
Aquestive Therapeutics, Inc. (AQST)United States$0.606B-6.67
IMPACT BIOMEDICAL INC. (IBO)United States$0.611B66.47
Phathom Pharmaceuticals, Inc. (PHAT)United States$0.572B-8.76
Neurogene Inc. (NGNE)$0.625B-4.46
Shattuck Labs, Inc. (STTK)United States$0.634B-13.30
BlossomHill Therapeutics, Inc. (BLSM)United States$0.647B
Indaptus Therapeutics, Inc. (INDP)United States$0.537B